OpGen, Inc. (OTC:OPGN – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $72.26 and last traded at $72.26, with a volume of 674413 shares. The stock had previously closed at $28.00.
OpGen Trading Down 17.2%
The firm’s 50-day moving average price is $16.89 and its two-hundred day moving average price is $7.67. The stock has a market cap of $283.50 million, a PE ratio of -5.05 and a beta of -1.77.
OpGen Company Profile
OpGen, Inc (NASDAQ: OPGN) is a precision medicine company specializing in molecular diagnostics and digital solutions for infectious disease management. Leveraging next-generation sequencing, bioinformatics and molecular assay technologies, OpGen develops tools designed to detect microbial pathogens and antimicrobial resistance markers rapidly and accurately. The company’s mission is to support clinicians and laboratories in making timely, informed treatment decisions that help curb the spread of drug-resistant infections.
Among OpGen’s key offerings is the Acuitas® AMR Gene Panel, a suite of molecular assays that identify genetic determinants of antibiotic resistance directly from positive blood cultures.
Featured Stories
- Five stocks we like better than OpGen
- USAU: The U.S. Gold-Copper Story Investors Can’t Ignore.
- The DoD just got a new drone supplier
- Most Investors Aren’t Looking at This Side of Clean Energy
- My Epstein Story
- When to buy gold (mathematically)
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
